Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

HCCR-1-interacting molecule "deleted in polyposis 1" plays a tumor-suppressor role in colon carcinogenesis.

Shin SM, Chung YJ, Oh ST, Jeon HM, Hwang LJ, Namkoong H, Kim HK, Cho GW, Hur SY, Kim TE, Lee YS, Park YG, Ko J, Kim JW.

Gastroenterology. 2006 Jun;130(7):2074-86.

PMID:
16762630
2.

Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization.

Ko J, Lee YH, Hwang SY, Lee YS, Shin SM, Hwang JH, Kim J, Kim YW, Jang SW, Ryoo ZY, Kim IK, Namkoong SE, Kim JW.

Oncogene. 2003 Jul 24;22(30):4679-89.

PMID:
12879013
3.

ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.

Herbst A, Bommer GT, Kriegl L, Jung A, Behrens A, Csanadi E, Gerhard M, Bolz C, Riesenberg R, Zimmermann W, Dietmaier W, Wolf I, Brabletz T, Göke B, Kolligs FT.

Gastroenterology. 2009 Aug;137(2):639-48, 648.e1-9. doi: 10.1053/j.gastro.2009.04.049. Epub 2009 Apr 23.

PMID:
19394332
4.

The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression.

Cho GW, Shin SM, Namkoong H, Kim HK, Ha SA, Hur SY, Kim TE, Chai YG, Kim JW.

Gene. 2006 Dec 15;384:18-26. Epub 2006 Jul 20.

PMID:
16949218
5.

The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.

Yoon SK, Lim NK, Ha SA, Park YG, Choi JY, Chung KW, Sun HS, Choi MJ, Chung J, Wands JR, Kim JW.

Cancer Res. 2004 Aug 1;64(15):5434-41.

6.

The HCCR oncoprotein as a biomarker for human breast cancer.

Jung SS, Park HS, Lee IJ, Namkoong H, Shin SM, Cho GW, Ha SA, Park YG, Lee YS, Ko J, Kim JW.

Clin Cancer Res. 2005 Nov 1;11(21):7700-8.

7.

TCF/beta-catenin plays an important role in HCCR-1 oncogene expression.

Cho GW, Kim MH, Kim SH, Ha SA, Kim HK, Kim S, Kim JW.

BMC Mol Biol. 2009 May 12;10:42. doi: 10.1186/1471-2199-10-42.

8.

Kruppel-like factor 6 (KLF6) is a tumor-suppressor gene frequently inactivated in colorectal cancer.

Reeves HL, Narla G, Ogunbiyi O, Haq AI, Katz A, Benzeno S, Hod E, Harpaz N, Goldberg S, Tal-Kremer S, Eng FJ, Arthur MJ, Martignetti JA, Friedman SL.

Gastroenterology. 2004 Apr;126(4):1090-103.

PMID:
15057748
9.

Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice.

Ko J, Shin SM, Oh YM, Lee YS, Ryoo ZY, Lee YH, Na DS, Kim JW.

Oncogene. 2004 Mar 11;23(10):1950-3.

PMID:
14691448
10.

Screening of tumor suppressor genes on 1q31.1-32.1 in Chinese patients with sporadic colorectal cancer.

Zhou CZ, Qiu GQ, Wang XL, Fan JW, Tang HM, Sun YH, Wang Q, Huang F, Yan DW, Li DW, Peng ZH.

Chin Med J (Engl). 2008 Dec 20;121(24):2479-86.

PMID:
19187582
11.

HCCRBP-3 induces tumorigenesis through direct interaction with HCCR-1 in human cancers.

Ha SA, Kim HK, Yoo JA, Kim S, Shin SM, Gong GH, Lee YK, Kim JW.

Mol Carcinog. 2014 Jan;53(1):30-7. doi: 10.1002/mc.21945. Epub 2012 Jul 31.

PMID:
22851403
12.

HCCRBP-1 directly interacting with HCCR-1 induces tumorigenesis through P53 stabilization.

Ha SA, Shin SM, Lee YJ, Kim S, Kim HK, Namkoong H, Lee H, Lee YS, Cho YS, Park YG, Jeon HM, Oh C, Kim JW.

Int J Cancer. 2008 Feb 1;122(3):501-8.

13.

N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.

Melotte V, Lentjes MH, van den Bosch SM, Hellebrekers DM, de Hoon JP, Wouters KA, Daenen KL, Partouns-Hendriks IE, Stessels F, Louwagie J, Smits KM, Weijenberg MP, Sanduleanu S, Khalid-de Bakker CA, Oort FA, Meijer GA, Jonkers DM, Herman JG, de Bruïne AP, van Engeland M.

J Natl Cancer Inst. 2009 Jul 1;101(13):916-27. doi: 10.1093/jnci/djp131. Epub 2009 Jun 17.

PMID:
19535783
14.

IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1.

Ruan WJ, Lin J, Xu EP, Xu FY, Ma Y, Deng H, Huang Q, Lv BJ, Hu H, Cui J, Di MJ, Dong JK, Lai MD.

J Zhejiang Univ Sci B. 2006 Nov;7(11):929-32.

15.

Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.

Yekkala K, Baudino TA.

Mol Cancer Res. 2007 Dec;5(12):1296-303. doi: 10.1158/1541-7786.MCR-07-0232. Erratum in: Mol Cancer Res. 2008 Feb;6(2):340.

16.

Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.

Bianchini M, Levy E, Zucchini C, Pinski V, Macagno C, De Sanctis P, Valvassori L, Carinci P, Mordoh J.

Int J Oncol. 2006 Jul;29(1):83-94.

PMID:
16773188
17.

IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis.

Ruan W, Xu E, Xu F, Ma Y, Deng H, Huang Q, Lv B, Hu H, Lin J, Cui J, Di M, Dong J, Lai M.

Cancer Biol Ther. 2007 Mar;6(3):354-9. Epub 2007 Mar 12.

PMID:
17312390
18.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
19.

Down-regulation of FHIT inhibits apoptosis of colorectal cancer: mechanism and clinical implication.

Cao J, Li W, Xie J, Du H, Tang W, Wang H, Chen X, Xiao W, Li Y.

Surg Oncol. 2006 Dec;15(4):223-33. Epub 2007 Mar 26.

PMID:
17382535
20.

Genetic alterations of APC, K-ras, p53, MSI, and MAGE in Korean colorectal cancer patients.

Jeon CH, Lee HI, Shin IH, Park JW.

Int J Colorectal Dis. 2008 Jan;23(1):29-35. Epub 2007 Aug 18.

PMID:
17704924

Supplemental Content

Support Center